Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Nasopharyngeal Carcinoma 26Prostatic Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Nasopharyngeal Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 5Uterine Cervical Neoplasms 4Oropharyngeal Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tongue Neoplasms 2Salivary Gland Neoplasms 2Radiation Injuries 2Neurotoxicity Syndromes 2Hypopharyngeal Neoplasms 2Glioblastoma 2Carcinoma 2Brain Neoplasms 2Astrocytoma 2Vaginal Neoplasms 1Thoracic Neoplasms 1Stage II Prostate Adenocarcinoma AJCC v7 1Sarcoma 1Precancerous Conditions 1Postoperative Complications 1Papillomavirus Infections 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ototoxicity 1Oligodendroglioma 1

Interventions

Carboplatin 5Pemetrexed 4pembrolizumab 3Paclitaxel 3Gemcitabine 2Erlotinib Hydrochloride 2Cisplatin 2pralsetinib 1patritumab 1napabucasin 1camrelizumab 1Vinorelbine 1TNFSF10 protein, human 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Injections 1Gefitinib 1Docetaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Thoracic Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT00880971 2020-10-05

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

ChineseAMS

Phase 3 Completed
394 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡